Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2

Conditions

Stomach Neoplasms 3Colorectal Neoplasms 3Lung Neoplasms 2Colonic Neoplasms 2Venous Thrombosis 1Pancreatic Ductal Adenocarcinoma 1Malignant Neoplasm of Transverse Colon 1Locally Advanced Gastric Cancer 1Endometrial Neoplasms 1Colorectal Liver Metastasis 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 38Carboplatin 28Gemcitabine 23Docetaxel 20Radiotherapy 18Etoposide 15Paclitaxel 13Erlotinib Hydrochloride 13Vinorelbine 11Drug Therapy 11pembrolizumab 9aumolertinib 9apatinib 9Pemetrexed 9Gefitinib 9osimertinib 7endostar protein 7Thoracic Surgery, Video-Assisted 7Blood Specimen Collection 7camrelizumab 6anlotinib 6Vinblastine 6Surgical Procedures, Operative 6sintilimab 5Radiosurgery 5Fluorodeoxyglucose F18 5Cyclophosphamide 5Bevacizumab 5durvalumab 4Mitomycin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Lung Neoplasms × Conversion to Open Surgery × Clear all
NCT05674227 2023-02-01

Cost-effectiveness Evaluation of Robotic Surgery in the Removal of Lung Lesions in the ATS of Milan

Agenzia di Tutela della Salute della Città Metropolitana di Milano

Unknown
5,400 enrolled
Thoracic

Lung Neoplasms

NCT04009915 2022-05-09

VOLCANO

Shanghai Pulmonary Hospital, Shanghai, China

Phase 3 Unknown
200 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡